American International Group, Inc. Point Biopharma Global Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.67 - $9.71 $10,705 - $15,584	1,605 Added 3.69%	45,158 $301,000
Q2 2023 Aug 04, 2023	BUY	$6.86 - $10.86 $11,353 - $17,973	1,655 Added 3.95%	43,553 $394,000
Q1 2023 May 12, 2023	BUY	$6.78 - $8.1 $9,925 - $11,858	1,464 Added 3.62%	41,898 $304,000
Q4 2022 Feb 10, 2023	BUY	$5.72 - $9.78 $30,178 - $51,599	5,276 Added 15.01%	40,434 $294,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $3,598 - $5,124	497 Added 1.43%	35,158 $272,000
Q2 2022 Aug 12, 2022	BUY	$5.6 - $9.5 $194,101 - $329,279	34,661 New	34,661 $236,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.